Screening for Prostate Cancer 300 Times More Sensitive Than Current Tests
Screening breakthrough detects PSA levels that other tests read as zero, and could provide men who had their prostates removed but still have cancer with safer, earlier treatments.
Interview With Fred Robertson, President & CEO of TomoTherapy
TomoTherapy president and CEO Fred Robertson talks with DOTmed about his perspective on ASTRO's 2009 annual meeting, changes in the radiation oncology industry and two important TomoTherapy product launches that occurred at the show. Watch the HD video.
BRIT Releases WebWorks
Browser-based application for viewing patient studies and reports anytime, anywhere.
U.S. Preventive Services Task Force Has Stunning New Guidelines on Mammography
Agency recommends no routine screening for women 40-49, no self-examination. Read the details.
AHA: Patient Follow-Up With Melody Transcatheter Valve After One Year
On Monday, Medtronic shared the latest results of their highly-anticipated Melody transcatheter valve.
